Protective effect of pristane on experimental autoimmune uveitis

Immunology Letters

Volumn 141, Issue 1, 2011, Pages 83-93

  Daudin, Jean Baptiste ^a,b   Monnet, Dominique ^b   Kavian, Niloufar ^a   Espy, Cécile ^a   Wang, Andrew ^c   Chéreau, Christiane ^a   Goulvestre, Claire ^a   Omri, Samy ^d   Brézin, Antoine ^b   Weill, Bernard ^a   Batteux, Frédéric ^a   Nicco, Carole ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b AP HP ^*  (France)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

Experimental autoimmune uveitis; Phytol; Pristane; ROS

Indexed keywords

ACETYLCYSTEINE; CD11B ANTIGEN; CD45 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; HERMES ANTIGEN; HYDROGEN PEROXIDE; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 17; INTERLEUKIN 4; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN[1-20]; L SELECTIN; OCCLUDIN; PHYTOL; PRISTANE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; BLOOD RETINA BARRIER; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOWN REGULATION; DRUG RESPONSE; EFFECTOR CELL; ENDOTHELIUM CELL; EXPERIMENTAL AUTOIMMUNE UVEITIS; FEMALE; HUMAN; HUMAN CELL; IMMUNIZATION; INCIDENCE; INTERFERON PRODUCTION; LEUKOCYTE; LYMPH NODE CELL; MACROPHAGE; MEMORY T LYMPHOCYTE; MONOCYTE; MOUSE; MYELOID DENDRITIC CELL; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINITIS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TIGHT JUNCTION; UVEITIS; VASCULITIS;

ACETYLCYSTEINE; ANIMALS; AUTOIMMUNITY; CELL LINE; DISEASE MODELS, ANIMAL; EYE; EYE PROTEINS; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYDROGEN PEROXIDE; IMMUNIZATION; IMMUNOGLOBULIN G; INTERLEUKIN-17; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PHYTOL; RETINOL-BINDING PROTEINS; TERPENES; UVEITIS;

EID: 80955158426     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2011.07.009     Document Type: Article

References (42)

1. Agarwal R.K., Caspi R.R. Rodent models of experimental autoimmune uveitis. Methods Mol Med 2004, 102:395-419.
2. Adamus G., Chan C.C. Experimental autoimmune uveitides: multiple antigens, diverse diseases. Int Rev Immunol 2002, 21:209-229.
3. Caspi R.R. Experimental autoimmune uveoretinitis in the rat and mouse. Curr Protoc Immunol 2003, [chapter 15:unit 15 16].
4. Shao H., Liao T., Ke Y., Shi H., Kaplan H.J., Sun D. Severe chronic experimental autoimmune uveitis (EAU) of the C57BL/6 mouse induced by adoptive transfer of IRBP1-20-specific T cells. Exp Eye Res 2006, 82:323-331.
5. Luger D., Silver P.B., Tang J., Cua D., Chen Z., Iwakura Y., et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 2008, 205:799-810.
6. Caspi R.R. Th1 and Th2 responses in pathogenesis and regulation of experimental autoimmune uveoretinitis. Int Rev Immunol 2002, 21:197-208.
7. Harzallah O., Kerkeni A., Baati T., Mahjoub S. Oxidative stress: correlation with Behcet's disease duration, activity and severity. Eur J Intern Med 2008, 19:541-547.
8. Bosch-Morell F., Roma J., Marin N., Romero B., Rodriguez-Galietero A., Johnsen-Soriano S., et al. Role of oxygen and nitrogen species in experimental uveitis: anti-inflammatory activity of the synthetic antioxidant ebselen. Free Radic Biol Med 2002, 33:669-675.
9. Bosch-Morell F., Roma J., Puertas F.J., Marin N., Diaz-Llopis M., Romero F.J. Efficacy of the antioxidant ebselen in experimental uveitis. Free Radic Biol Med 1999, 27:388-391.
10. Liversidge J., Dick A., Gordon S. Nitric oxide mediates apoptosis through formation of peroxynitrite and Fas/Fas-ligand interactions in experimental autoimmune uveitis. Am J Pathol 2002, 160:905-916.
11. Rintisch C., Forster M., Holmdahl R. Detection of arthritis-susceptibility loci, including Ncf1, and variable effects of the major histocompatibility complex region depending on genetic background in rats. Arthritis Rheum 2009, 60:419-427.
12. Hultqvist M., Olofsson P., Gelderman K.A., Holmberg J., Holmdahl R. A new arthritis therapy with oxidative burst inducers. PLoS Med 2006, 3:e348.
13. Ronda N., Leonardi S., Orlandini G., Gatti R., Bellosta S., Bernini F., et al. Natural anti-endothelial cell antibodies (AECA). J Autoimmun 1999, 13:121-127.
14. Caspi R.R. Regulation, counter-regulation, and immunotherapy of autoimmune responses to immunologically privileged retinal antigens. Immunol Res 2003, 27:149-160.
15. Tarrant T.K., Silver P.B., Chan C.C., Wiggert B., Caspi R.R. Endogenous IL-12 is required for induction and expression of experimental autoimmune uveitis. J Immunol 1998, 161:122-127.
16. Preud'homme J.L., Rochard E., Gouet D., Danon F., Alcalay M., Touchard G., et al. Isotypic distribution of anti-double-stranded DNA antibodies: a diagnostic evaluation by enzyme-linked immunosorbent assay. Diagn Clin Immunol 1988, 5:256-261.
17. Witko V., Nguyen A.T., Descamps-Latscha B. Microtiter plate assay for phagocyte-derived taurine-chloramines. J Clin Lab Anal 1992, 6:47-53.
18. Combadiere C., Feumi C., Raoul W., Keller N., Rodero M., Pezard A., et al. CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest 2007, 117:2920-2928.
19. Israeli E., Agmon-Levin N., Blank M., Shoenfeld Y. Adjuvants and autoimmunity. Lupus 2009, 18:1217-1225.
20. Satoh M., Kumar A., Kanwar Y.S., Reeves W.H. Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. Proc Natl Acad Sci USA 1995, 92:10934-10938.
21. Zhang L., Mia M.Y., Zheng C.L., Hossain M.A., Yamasaki F., Tokunaga O., et al. The preventive effects of incomplete Freund's adjuvant and other vehicles on the development of adjuvant-induced arthritis in Lewis rats. Immunology 1999, 98:267-272.
22. Kuroda Y., Akaogi J., Nacionales D.C., Wasdo S.C., Szabo N.J., Reeves W.H., et al. Distinctive patterns of autoimmune response induced by different types of mineral oil. Toxicol Sci 2004, 78:222-228.
23. Satoh M., Reeves W.H. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med 1994, 180:2341-2346.
24. Satoh M., Richards H.B., Shaheen V.M., Yoshida H., Shaw M., Naim J.O., et al. Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane. Clin Exp Immunol 2000, 121:399-405.
25. Mizukawa Y., Yamazaki Y., Teraki Y., Hayakawa J., Hayakawa K., Nuriya H., et al. Direct evidence for interferon-gamma production by effector-memory-type intraepidermal T cells residing at an effector site of immunopathology in fixed drug eruption. Am J Pathol 2002, 161:1337-1347.
26. Amadi-Obi A., Yu C.R., Liu X., Mahdi R.M., Clarke G.L., Nussenblatt R.B., et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 2007, 13:711-718.
27. Rizzo L.V., Valochi A.L. Lessons to be learned from experimental uveitis. Dev Ophthalmol 1999, 31:22-30.
28. Tang J., Zhu W., Silver P.B., Su S.B., Chan C.C., Caspi R.R. Autoimmune uveitis elicited with antigen-pulsed dendritic cells has a distinct clinical signature and is driven by unique effector mechanisms: initial encounter with autoantigen defines disease phenotype. J Immunol 2007, 178:5578-5587.
29. Caspi R.R., Sun B., Agarwal R.K., Silver P.B., Rizzo L.V., Chan C.C., et al. T cell mechanisms in experimental autoimmune uveoretinitis: susceptibility is a function of the cytokine response profile. Eye 1997, 11(Pt. 2):209-212.
30. Sun B., Rizzo L.V., Sun S.H., Chan C.C., Wiggert B., Wilder R.L., et al. Genetic susceptibility to experimental autoimmune uveitis involves more than a predisposition to generate a T helper-1-like or a T helper-2-like response. J Immunol 1997, 159:1004-1011.
31. Luger D., Caspi R.R. New perspectives on effector mechanisms in uveitis. Semin Immunopathol 2008, 30:135-143.
32. Pennesi G., Mattapallil M.J., Sun S.H., Avichezer D., Silver P.B., Karabekian Z., et al. A humanized model of experimental autoimmune uveitis in HLA class II transgenic mice. J Clin Invest 2003, 111:1171-1180.
33. Sun B., Sun S.H., Chan C.C., Wiggert B., Caspi R.R. Autoimmunity to a pathogenic retinal antigen begins as a balanced cytokine response that polarizes towards type 1 in a disease-susceptible and towards type 2 in a disease-resistant genotype. Int Immunol 1999, 11:1307-1312.
34. Calvani N., Caricchio R., Tucci M., Sobel E.S., Silvestris F., Tartaglia P., et al. Induction of apoptosis by the hydrocarbon oil pristane: implications for pristane-induced lupus. J Immunol 2005, 175:4777-4782.
35. Holmdahl R., Lorentzen J.C., Lu S., Olofsson P., Wester L., Holmberg J., et al. Arthritis induced in rats with nonimmunogenic adjuvants as models for rheumatoid arthritis. Immunol Rev 2001, 184:184-202.
36. Griffiths H.R. Is the generation of neo-antigenic determinants by free radicals central to the development of autoimmune rheumatoid disease?. Autoimmun Rev 2008, 7:544-549.
37. Perricone C., De Carolis C., Perricone R. Glutathione: a key player in autoimmunity. Autoimmun Rev 2009, 8:697-701.
38. Ohia S.E., Opere C.A., Leday A.M. Pharmacological consequences of oxidative stress in ocular tissues. Mutat Res 2005, 579:22-36.
39. Bailey T.A., Kanuga N., Romero I.A., Greenwood J., Luthert P.J., Cheetham M.E. Oxidative stress affects the junctional integrity of retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2004, 45:675-684.
40. Luna J.D., Chan C.C., Derevjanik N.L., Mahlow J., Chiu C., Peng B., et al. Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1beta-mediated breakdown. J Neurosci Res 1997, 49:268-280.
41. Caspi R.R. Ocular autoimmunity: the price of privilege?. Immunol Rev 2006, 213:23-35.
42. Caspi R.R., Chan C.C., Fujino Y., Najafian F., Grover S., Hansen C.T., et al. Recruitment of antigen-nonspecific cells plays a pivotal role in the pathogenesis of a T cell-mediated organ-specific autoimmune disease, experimental autoimmune uveoretinitis. J Neuroimmunol 1993, 47:177-188.